Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC

NCT03370406 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Squamous Cell

Interventions

DRUG: 5-fluorouracil
DRUG: Calcipotriene

Sponsor

Melissa Pugliano-Mauro

Collaborators

[object Object]